SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune -- Ignore unavailable to you. Want to Upgrade?

To: bill small who wrote (136)9/9/1998 10:51:00 AM
From: Dave Walp  Respond to of 416
 
I don't care too much why its moving, just that it is (moving up, that is). Yeah, I own a little. I've often bought it high and watched it dive. Always comes back, though. Expect to stay long for the foreseeable future.

Dave



To: bill small who wrote (136)11/25/1998 8:52:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 416
 
Yesterday, BancBoston Robertson Stephens (BBRS) held a conference call on the Health Sciences Conference which begins on Monday in NY. They mentioned several companies, including MEDI. Details linked to the Biotech Boom table at biocognizance.com or webf2179.ntx.net



To: bill small who wrote (136)1/5/1999 2:26:00 PM
From: bill small  Read Replies (1) | Respond to of 416
 
Is anyone else worried that Hockmeyer and Mott have sold ALL their MEDI shares?

I can see selling some of your company shares for diversification but don't think it a good sign if all are sold. As far as I know things are going well at company but this selling is disturbing to say the least.

anyone out there with some words of wisdom????


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News